GlassScriptPhysician profile
Triet Nguyen
NPI 1306807789
$103,215.59
in general payments reported to CMS, 2019-2025
38 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,211 · 2021: $13K · 2022: $27K · 2023: $19K · 2024: $7,902 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,015 · Travel and Lodging: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25,818.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,540.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,015.00 |
| Travel and Lodging | $694.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $51,674.16 | 2019-2025 | Cequa, Xelpros, Bromsite |
| Bausch & Lomb Americas INC. | $4,682.31 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $4,343.96 | 2021-2025 | Rocklatan, Hydrus Microstent, Tryptyr |
| Mallinckrodt Hospital Products INC. | $4,186.60 | 2020-2025 | Acthar |
| Allergan, INC. | $4,031.66 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $3,735.04 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $3,677.73 | 2019-2023 | Tobradex St, Flarex |
| Oyster Point Pharma, INC. | $3,477.38 | 2022-2025 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $2,885.92 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,709.06 | 2019-2021 | |
| Abbvie INC. | $2,431.90 | 2022-2025 | |
| Dompe US, INC. | $2,044.89 | 2021-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $1,939.91 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $1,930.65 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $1,230.72 | 2024-2025 | Vevye, Iheezo, Natacyn |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,061.58 | 2024-2025 | Tepezza |
| Ani Pharmaceuticals, INC. | $1,019.03 | 2024-2025 | Purified Cortrophin Gel |
| Horizon Therapeutics Plc | $945.22 | 2021-2023 | Tepezza |
| Shire North American Group INC | $804.15 | 2019 | |
| Ivantis, INC | $788.31 | 2019-2021 | |
| Akorn, INC. | $705.71 | 2019-2020 | |
| Akorn Operating Company LLC | $686.41 | 2021 | |
| Thea Pharma INC. | $524.14 | 2022-2025 | Iyuzeh |
| Sight Sciences, INC. | $335.07 | 2020-2024 | Omni Surgical System |
| Glaukos Corporation | $199.84 | 2021-2023 | Gsw-Istentinjectwtrabecular Micro-Bypass System, Istent Inject Trabecular Micro-Bypass System, Istent Inject Trabecular Micro-Bypass System |
| Carl Zeiss Meditec USA, INC. | $188.77 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $180.87 | 2019 | |
| Rxsight INC | $166.42 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Astellas Pharma US INC | $134.29 | 2025 | Izervay |
| Gilead Sciences, INC. | $120.25 | 2025 | Vemlidy |
| Optos, INC. | $96.01 | 2021-2022 | |
| Lensar, INC. | $75.80 | 2024 | Lensar Laser System |
| Ocular Therapeutix, INC. | $63.29 | 2023 | Dextenza |
| Rayner Intraocular Lenses Limited | $53.02 | 2025 | Omidria |
| Integra Lifesciences Corporation | $36.56 | 2021 | |
| Mallinckrodt Enterprises LLC | $20.78 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Quidel Corporation | $8.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Triet Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.